Gonzalo Quesada
Psychiatry · Hialeah Gardens, FLNPI 1649484122
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 9 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Neurocrine Biosciences, Inc. accounts for 84.8% of it on its own, with 1 other manufacturer making up the rest.
Across 9 payments — averaging $82.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$633
- Johnson & Johnson$113
Across 110 payments — averaging $27,704 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$826K
- Amgen$586K
- E.r. Squibb & Sons, L.L.C.$475K
- Vertex$455K
- Novartis$280K
- Orexo US, Inc.$273K
- plus $154K from 3 others
What the payments were for
- Food & beverage$746100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 8 | $633 |
| Johnson & Johnson | 1 | $113 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$113
How this compares
$746 in reported general payments places this provider in the 55th percentile of 2,059 psychiatry providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 25 | $1,254 |
| Clonazepam | 48 | $650 |
| Escitalopram Oxalate | 12 | $325 |
| Sertraline Hcl | 25 | $304 |
| Lamotrigine | 20 | $266 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 12 | $203 |
| Lurasidone Hcl | 11 | $190 |
| Gabapentin | 12 | $162 |
| Aripiprazole | 13 | $64 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Hialeah Gardens
- Andrew CutlerLakewood Ranch$5.7M
- Richard JacksonBoca Raton$3.6M
- Ilan MelnickCoral Gables$2.8M
- Todd BroderSt Augustine$1.6M
- Heather LuingSaint Augustine$1.5M
- Todd GatesWest Melbourne$1.2M
- Lawrence ReccoppaGainesville$968K
- Thomas ValenteLeesburg$967K
- Michelle ScargleClearwater$926K
- David SheehanTampa$631K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.